Publicaties
Poor antibody response to BioNTech/Pfizer coronavirus disease 2019 vaccination in severe acute respiratory syndrome coronavirus 2 – naive residents of nursing homes Universiteit Gent Instituut voor Tropische Geneeskunde Universiteit Antwerpen
Chronic Histiocytic Intervillositis With Trophoblast Necrosis Is a Risk Factor Associated With Placental Infection From Coronavirus Disease 2019 (COVID-19) and Intrauterine Maternal-Fetal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transm KU Leuven
Respiratory management in severe acute respiratory syndrome coronavirus 2 infection Universiteit Hasselt
Can public trust coronavirus apps? Instituut voor Tropische Geneeskunde KU Leuven
Differences and Similarities Among Coronavirus Disease 2019 Patients Treated in Seven ICUs in Three Countries Within One Region Universiteit Hasselt
Outbreak of Middle East respiratory syndrome coronavirus in camels and probable spillover infection to humans in Kenya Instituut voor Tropische Geneeskunde
The majority of Kenya's > 3 million camels have antibodies against Middle East respiratory syndrome coronavirus (MERS-CoV), although human infection in Africa is rare. We enrolled 243 camels aged 0-24 months from 33 homesteads in Northern Kenya and followed them between April 2018 to March 2020. We collected and tested camel nasal swabs for MERS-CoV RNA by RT-PCR followed by virus isolation and whole genome sequencing of positive ...
Ventilator-associated bacterial pneumonia in coronavirus 2019 disease, a retrospective monocentric cohort study Vrije Universiteit Brussel
INTRODUCTION: Severe coronavirus 2019 disease (CoViD-19) may lead to respiratory failure and mechanical ventilation. Therefore, ventilator associated pneumonia (VAP) may complicate the course of the disease. The aim of the current article was to investigate possible predictive factors for bacterial VAP on a retrospective manner, in a cohort of mechanically ventilated CoViD-19 patients. Additionally, determinant factors of lethality were ...